RARECYTE INC.
History
| Year | Detail |
|---|---|
| 2009 | RareCyte is an American company founded in 2009 and based in Seattle. It is a Precision biology company developing high-performance microscopes dedicated to pathology samples and biopsies, including liquid and tissue biopsies. |
| 2015 | The company launched its first commercial product with the release of the CyteFinder Imaging Instrument. |
| 2021 | The company launched Synaptophysin CTC assay for blood-based characterization of treatment-resistant malignancies. |
| 2024 | SOPHiA GENETICS, a cloud-native software company, announced that RareCyte has implemented the SOPHiA DDM Platform to complement its precision biology services portfolio. |
| 2024 | Navigate BioPharma Services, Inc. collaborated with RareCyte, Inc. to provide enhanced spatial biology capabilities using the Orion Platform. |
BCC Research Beacon 